Business Context and Reporting Period
This Form 8-K Current Report was filed by NextDecade Corporation on September 25, 2018. The filing reports on the results of a special meeting of stockholders held on the same date to vote on matters related to a Series B Convertible Preferred Stock Purchase Agreement entered into on August 23, 2018, with funds managed by BlackRock.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, or debt levels. The primary financial data disclosed relates to the capital raise transaction:
- Series B Convertible Preferred Stock Issuance: $29.055 million approved for issuance.
- Additional Authorization: Up to $20.945 million of additional Series B Convertible Preferred Stock authorized for future issuance.
Material Changes
The material change reported is the successful shareholder approval of the capital raise transaction. Prior to this filing, the issuance of the Series B Convertible Preferred Stock and associated warrants was contingent upon stockholder approval. The filing confirms the completion of this condition.
Voting Results and Management Commentary
The special meeting resulted in the approval of three proposals with overwhelming support:
- Proposal 1: Approval of the $29.055 million Series B issuance.
- For: 106,024,058
- Against: 14,033
- Withhold/Abstain: 200
- Proposal 2: Authorization to issue up to an additional $20.945 million of Series B stock on similar terms.
- For: 106,023,488
- Against: 14,033
- Withhold/Abstain: 770
- Proposal 3: Authorization to grant Series A holders pro rata rights to purchase future Series C Convertible Preferred Stock.
- For: 106,014,058
- Against: 24,033
- Withhold/Abstain: 200
The filing text does not contain specific management commentary, forward-looking guidance, or a discussion of risks and contingencies beyond the context of the voting proposals.
Investor Verification Checklist
- Verify the final closing date and actual proceeds received from the $29.055 million Series B issuance.
- Review the specific terms of the associated Warrants mentioned in the purchase agreement.
- Confirm the dilution impact of the approved Series B issuance and the potential additional $20.945 million authorization on existing common and preferred shareholders.
- Check subsequent filings for the exercise of the pro rata rights granted to Series A holders regarding future Series C stock.